Small-cell lung cancer (SCLC) comprises approximately 14% of all lung cancer cases. Most patients present with locally advanced or metastatic disease and are therefore treated nonoperatively with chemotherapy, radiotherapy, or both. A small subset of patients with SCLC present with early-stage disease and will benefit from surgical resection plus chemotherapy. The rationale for radiotherapy in these patients remains controversial.
- Early-stage small cell lung cancer
- Lung resection
- Small cell lung cancer
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine